ROIV - Wall Street Estimates - Roivant Sciences Ltd.

Healthcare - Biotechnology - NASDAQ - GB

$ 10.505

-2.19 %

$ 7.5 B

Market Cap

-10.5

P/E

Price Target Average

58.85%

Revenue Forecast Estimate

99.80%

EBIT Estimate

--10.09%

Net Income Estimate

--48.16%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Roivant Sciences Ltd.

Wall Street analysts predict an average 1-year price target for ROIV of $16.7 , with forecasts ranging from a low of $12.5 to a high of $20 .

ROIV Lowest Price Target Wall Street Target

12.5 USD 18.99%

ROIV Average Price Target Wall Street Target

16.7 USD 58.85%

ROIV Highest Price Target Wall Street Target

20 USD 90.39%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free